Cancer combo trial halted early after enrolling only 3 patients
Disease control
Terminated
This study tested a new drug called CX-072 combined with other cancer treatments in adults with advanced solid tumors or melanoma. The goal was to see if the combination could shrink tumors. However, the trial was stopped early after enrolling only 3 people, so results are very l…
Phase: PHASE2 • Sponsor: CytomX Therapeutics • Aim: Disease control
Last updated Apr 26, 2026 20:01 UTC